37
In band
Moving averages
SMA 200$19.26-10.12%
Company profile
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$2.16B
P/E ratioNone
EPS$-1.57
Beta0.261
Dividend yield0.00%
52-week high$25.32
52-week low$14.68
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 43
VRTX
Vertex Pharmaceuticals Inc
RSI 38
CRSP
CRISPR Therapeutics AG
RSI 46
IOVA
Iovance Biotherapeutics Inc
RSI 66
MRNA
Moderna Inc
RSI 60
VKTX
Viking Therapeutics Inc
RSI 39
EDIT
Editas Medicine Inc
RSI 49
IBRX
ImmunityBio Inc
RSI 61
NVAX
Novavax Inc
RSI 60
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 63
RSI alerts for SRPT
Get an email the moment Sarepta Therapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 4:55 AM EDT